Harlan S. Robins, Chief Scientific Officer at Adaptive Biotechnologies Corp (ADPT), sold 9,034 shares at $12.01 ($108K) on 2022-03-07, disclosed to the SEC on 2022-03-08.
Open-market sale of $108k ADPT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.01 | 4,517 | $54K | 50.0% |
| 2 | $12.01 | 4,517 | $54K | 50.0% |
| Total | $12.01 avg | 9,034 | $108K | 100% |
| Filing → |
| ADPT | SELL | 2026-06-17 | $1.8M | — | Filing → |
| ADPT | SELL | 2026-04-10 | $149K | — | Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |